Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024 Featured Updates to the NCCN Guidelines

被引:121
作者
Daly, Mary B. [1 ]
Pal, Tuya [2 ]
Maxwell, Kara N. [3 ]
Churpek, Jane [4 ]
Kohlmann, Wendy [5 ]
Alhilli, Zahraa [6 ,7 ]
Arun, Banu [8 ]
Buys, Saundra S. [5 ]
Cheng, Heather [9 ]
Domchek, Susan M. [3 ]
Friedman, Susan [10 ]
Giri, Veda [11 ]
Goggins, Michael [12 ]
Hagemann, Andrea [13 ,14 ]
Hendrix, Ashley [15 ]
Hutton, Mollie L. [16 ]
Karlan, Beth Y. [17 ]
Kassem, Nawal [18 ]
Khan, Seema [19 ]
Khoury, Katia [20 ]
Kurian, Allison W. [21 ]
Laronga, Christine [22 ]
Mak, Julie S. [23 ]
Mansour, John [24 ]
McDonnell, Kevin [25 ]
Menendez, Carolyn S. [26 ]
Merajver, Sofia D. [27 ]
Norquist, Barbara S. [9 ]
Offit, Kenneth [28 ]
Rash, Dominique [29 ]
Reiser, Gwen [30 ]
Senter-Jamieson, Leigha [31 ,32 ]
Shannon, Kristen Mahoney [33 ]
Visvanathan, Kala [12 ]
Welborn, Jeanna [34 ]
Wick, Myra J. [35 ]
Wood, Marie [36 ]
Yurgelun, Matthew B. [37 ]
Dwyer, Mary A. [38 ]
Darlow, Susan D. [38 ]
机构
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Vanderbilt Univ, Nashville, TN USA
[3] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
[4] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[5] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[6] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA
[7] Cleveland Clin Taussig Canc Inst, Cleveland, OH USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[9] Fred Hutchinson Canc Ctr, Seattle, WA USA
[10] FORCE Facing Our Risk Canc Empowered, Tampa, FL USA
[11] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA
[12] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[13] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA
[14] Washington Univ, Sch Med, St Louis, MO USA
[15] Univ Tennessee Hlth Sci Ctr, St Jude Childrens Res Hosp, Memphis, TN USA
[16] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[17] UCLA Jonsson Comprehens Canc Ctr, Los Angeles, CA USA
[18] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN USA
[19] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA
[20] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA
[21] Stanford Canc Inst, Stanford, CA USA
[22] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[23] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[24] UT Southwestern, Simmons Comprehens Canc Ctr, Dallas, TX USA
[25] City Hope Natl Med Ctr, Duarte, CA USA
[26] Duke Canc Inst, Durham, NC USA
[27] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA
[28] Mem Sloan Kettering Canc Ctr, New York, NY USA
[29] UC San Diego Moores Canc Ctr, San Diego, CA USA
[30] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA
[31] Ohio State Univ, James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA
[32] Solove Res Inst, Columbus, OH USA
[33] Mass Gen Canc Ctr, Boston, MA USA
[34] UC Davis Comprehens Canc Ctr, Sacramento, CA USA
[35] Mayo Clin, Comprehens Canc Ctr, Rochester, MI USA
[36] Univ Colorado, Canc Ctr, Denver, CO USA
[37] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[38] Natl Comprehens Canc Network, Plymouth Meeting, PA USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2023年 / 21卷 / 10期
关键词
LI-FRAUMENI-SYNDROME; TP53 MUTATION CARRIERS; GERMLINE MUTATION; IMAGING SURVEILLANCE; P53; MUTATIONS; CANCER-RISK; FOLLOW-UP; FAMILIES; LANDSCAPE; RHABDOMYOSARCOMA;
D O I
10.6004/jnccn.2023.0051
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on assessment of pathogenic/ likely pathogenic (P/LP) variants associated with increased risk of breast, ovarian, pancreatic, and prostate cancer, including BRCA1, BRCA2, CDH1, PALB2, PTEN, and TP53, and recommended approaches to genetic counseling/testing and care strategies in individuals with these P/LP variants. These NCCN Guidelines Insights summarize important up-dates regarding: (1) a new section for transgender, nonbinary and gender diverse people who have a hereditary predisposition to cancer focused on risk reduction strategies for ovarian cancer, uterine cancer, prostate cancer, and breast cancer; and (2) testing criteria and manage-ment associated with TP53 P/LP variants and Li-Fraumeni syndrome.J Natl Compr Canc Netw 2023;21(10):1000-1010doi:10.6004/jnccn.2023.0051
引用
收藏
页码:1000 / 1010
页数:11
相关论文
共 67 条
[1]   Prediction of acute myeloid leukaemia risk in healthy individuals [J].
Abelson, Sagi ;
Collord, Grace ;
Ng, Stanley W. K. ;
Weissbrod, Omer ;
Cohen, Netta Mendelson ;
Niemeyer, Elisabeth ;
Barda, Noam ;
Zuzarte, Philip C. ;
Heisler, Lawrence ;
Sundaravadanam, Yogi ;
Luben, Robert ;
Hayat, Shabina ;
Wang, Ting Ting ;
Zhao, Zhen ;
Cirlan, Julia ;
Pugh, Trevor J. ;
Soave, David ;
Ng, Karen ;
Latimer, Calli ;
Hardy, Claire ;
Raine, Keiran ;
Jones, David ;
Hoult, Diana ;
Britten, Abigail ;
McPherson, John D. ;
Johansson, Mattias ;
Mbabaali, Faridah ;
Eagles, Jenna ;
Millers, Jessica K. ;
Pasternack, Danielle ;
Timms, Lee ;
Krzyzanowski, Paul ;
Awadalla, Philip ;
Costa, Rui ;
Segal, Eran ;
Bratman, Scott, V ;
Beer, Philip ;
Behjati, Sam ;
Martincorena, Inigo ;
Wang, Jean C. Y. ;
Bowles, Kristian M. ;
Ramon Quiros, J. ;
Karakatsani, Anna ;
La Vecchia, Carlo ;
Trichopoulou, Antonia ;
Salamanca-Fernandez, Elena ;
Huerta, Jose M. ;
Barricarte, Aurelio ;
Travis, Ruth C. ;
Tumino, Rosario .
NATURE, 2018, 559 (7714) :400-+
[2]   Cancer Screening in Li-Fraumeni Syndrome [J].
Asdahl, Peter H. ;
Ojha, Rohit P. ;
Hasle, Henrik .
JAMA ONCOLOGY, 2017, 3 (12) :1645-1646
[3]   Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging A Meta-analysis [J].
Ballinger, Mandy L. ;
Best, Ana ;
Mai, Phuong L. ;
Khincha, Payal P. ;
Loud, Jennifer T. ;
Peters, June A. ;
Achatz, Maria Isabel ;
Chojniak, Rubens ;
da Costa, Alexandre Balieiro ;
Santiago, Karina Miranda ;
Garber, Judy ;
O'Neill, Allison F. ;
Eeles, Rosalind A. ;
Evans, D. Gareth ;
Bleiker, Eveline ;
Sonke, Gabe S. ;
Ruijs, Marielle ;
Loo, Claudette ;
Schiffman, Joshua ;
Naumer, Anne ;
Kohlmann, Wendy ;
Strong, Louise C. ;
Bojadzieva, Jasmina ;
Malkin, David ;
Rednam, Surya P. ;
Stoffel, Elena M. ;
Koeppe, Erika ;
Weitzel, Jeffrey N. ;
Slavin, Thomas P. ;
Nehoray, Bita ;
Robson, Mark ;
Walsh, Michael ;
Manelli, Lorenzo ;
Villani, Anita ;
Thomas, David M. ;
Savage, Sharon A. .
JAMA ONCOLOGY, 2017, 3 (12) :1634-1639
[4]   Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome [J].
Birch, JM ;
Blair, V ;
Kelsey, AM ;
Evans, DG ;
Harris, M ;
Tricker, KJ ;
Varley, JM .
ONCOGENE, 1998, 17 (09) :1061-1068
[5]   Molecular basis of the Li-Fraumeni syndrome:: an update from the French LFS families [J].
Bougeard, G. ;
Sesboue, R. ;
Baert-Desurmont, S. ;
Vasseur, S. ;
Martin, C. ;
Tinat, J. ;
Brugieres, L. ;
Chompret, A. ;
Paillerets, B. Bressac-de ;
Stoppa-Lyonnet, D. ;
Bonaiti-Pellie, C. ;
Frebourg, T. .
JOURNAL OF MEDICAL GENETICS, 2008, 45 (08) :535-538
[6]   Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers [J].
Bougeard, Gaelle ;
Renaux-Petel, Mariette ;
Flaman, Jean-Michel ;
Charbonnier, Camille ;
Fermey, Pierre ;
Belotti, Muriel ;
Gauthier-Villars, Marion ;
Stoppa-Lyonnet, Dominique ;
Consolino, Emilie ;
Brugieres, Laurence ;
Caron, Olivier ;
Benusiglio, Patrick R. ;
Bressac-de Paillerets, Brigitte ;
Bonadona, Valerie ;
Bonaiti-Pellie, Catherine ;
Tinat, Julie ;
Baert-Desurmont, Stephanie ;
Frebourg, Thierry .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (21) :2345-U33
[7]  
Brown A., 2022, About 5% of young adults in the U.S. say their gender is different from their sex assigned at birth
[8]   Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 Status [J].
Castillo, Danielle ;
Yuan, Tze-An ;
Nehoray, Bita ;
Cervantes, Aleck ;
Tsang, Kevin K. ;
Yang, Kai ;
Sand, Sharon R. ;
Mokhnatkin, Janet ;
Herzog, Josef ;
Slavin, Thomas P. ;
Hyman, Sophie ;
Schwartz, Alison ;
Ebert, Benjamin L. ;
Amos, Christopher I. ;
Garber, Judy E. ;
Weitzel, Jeffrey N. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (08) :1621-1629
[9]   Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study [J].
Cesar de Andrade, Kelvin ;
Khincha, Payal P. ;
Hatton, Jessica N. ;
Frone, Megan N. ;
Wegman-Ostrosky, Talia ;
Mai, Phuong L. ;
Best, Ana F. ;
Savage, Sharon A. .
LANCET ONCOLOGY, 2021, 22 (12) :1787-1798
[10]   The Li-Fraumeni syndrome [J].
Chompret, A .
BIOCHIMIE, 2002, 84 (01) :75-82